Paper3968643
Reactivity and possible significance of hydroxylamine and nitroso metabolites of procainamide.
Uetrecht JP. J Pharmacol Exp Ther, 1985. Cited by 99 papers, by iCite.
Cite this record
ConductScience Library. Reactivity and possible significance of hydroxylamine and nitroso metabolites of procainamide. Papers, record 3968643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3968643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA | Major topic |
| Procainamide | Major topic |
| Albumins | |
| Animals | |
| Glutathione | |
| Histones | |
| In Vitro Techniques | |
| Male | |
| Microsomes | |
| Protein Binding | |
| Rats | |
| Rats, Inbred Strains |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GM 31304 | NIGMS NIH HHS | United States | P01GM031304 | PubMed and NIH |
Source NIH RePORTER
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 99 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34281077 | Machine Learning for Predicting Risk of Drug-Induced Autoimmune Diseases by Structural Alerts and Daily Dose. | Int J Environ Res Public Health | 2021 | https://conductscience.org/library/papers/34281077 | PubMed |
| 30258789 | The use of structural alerts to avoid the toxicity of pharmaceuticals. | Toxicol Rep | 2018 | https://conductscience.org/library/papers/30258789 | PubMed |
| 22681489 | Role of reactive metabolites in the circulation in extrahepatic toxicity. | Expert Opin Drug Metab Toxicol | 2012 | https://conductscience.org/library/papers/22681489 | PubMed |
| 22387617 | Metabolomics reveals the metabolic map of procainamide in humans and mice. | Biochem Pharmacol | 2012 | https://conductscience.org/library/papers/22387617 | PubMed |
| 20972370 | Deleterious effects of reactive metabolites. | Oxid Med Cell Longev | 2010 | https://conductscience.org/library/papers/20972370 | PubMed |
| 20544243 | Acrylamine-induced autoimmune phenomena. | Clin Rheumatol | 2010 | https://conductscience.org/library/papers/20544243 | PubMed |
| 16594635 | Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin. | AAPS J | 2005 | https://conductscience.org/library/papers/16594635 | PubMed |
| 10502546 | Initiation of autoimmunity by a reactive metabolite of a lupus-inducing drug in the thymus. | Environ Health Perspect | 1999 | https://conductscience.org/library/papers/10502546 | PubMed |
| 9109433 | Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus. | J Clin Invest | 1997 | https://conductscience.org/library/papers/9109433 | PubMed |
| 7889834 | Reactions of oxidatively activated arylamines with thiols: reaction mechanisms and biologic implications. An overview. | Environ Health Perspect | 1994 | https://conductscience.org/library/papers/7889834 | PubMed |
| 7811401 | Mechanisms of unpredictable adverse drug reactions. | Drug Saf | 1994 | https://conductscience.org/library/papers/7811401 | PubMed |
| 2664753 | Idiosyncratic drug reactions: possible role of reactive metabolites generated by leukocytes. | Pharm Res | 1989 | https://conductscience.org/library/papers/2664753 | PubMed |
| 2590600 | Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes. | Br J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2590600 | PubMed |
| 2539397 | Metabolism of procainamide to the cytotoxic hydroxylamine by neutrophils activated in vitro. | J Clin Invest | 1989 | https://conductscience.org/library/papers/2539397 | PubMed |
| 2456755 | Metabolites of procainamide and practolol inhibit complement components C3 and C4. | Biochem J | 1988 | https://conductscience.org/library/papers/2456755 | PubMed |
| 2190593 | Immunotoxic side-effects of drug therapy. | Drug Saf | 1990 | https://conductscience.org/library/papers/2190593 | PubMed |
| 1793523 | Drug-related lupus. Incidence, mechanisms and clinical implications. | Drug Saf | 1991 | https://conductscience.org/library/papers/1793523 | PubMed |
| 1693889 | Acecainide (N-acetylprocainamide). A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiac arrhythmias. | Drugs | 1990 | https://conductscience.org/library/papers/1693889 | PubMed |
| 1685664 | Direct and metabolism-dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes. | Br J Clin Pharmacol | 1991 | https://conductscience.org/library/papers/1685664 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3968643
GET https://conductscience.org/api/papers/v1/3968643/authors